Zejula 100 mg – DIN 02530031
Zejula is Niraparib Tosylate 100 mg (tablet), sold in Canada. It is used for fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms. It is supplied by Glaxosmithkline Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Niraparib Tosylate 100 mg
- Brand
- Zejula
- Strength
- 100 mg
- Used for
- Fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms
- Form
- Tablet
- Manufacturer
- Glaxosmithkline Inc
- Drug class
- Poly(adp-ribose) polymerase inhibitor
- Sold in
- Canada
- DIN
- 02530031
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Niraparib used for?
Niraparib is used for fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms.
- Medicine type
- Poly(adp-ribose) polymerase inhibitor
Official uses from the US prescribing label
First-Line Maintenance Treatment of HRD-Positive Advanced Ovarian Cancer
ZEJULA is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD)-positive status defined by either:
- a deleterious or suspected deleterious BRCA mutation, and/or
- genomic instability.
Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.
Maintenance Treatment of Recurrent Germline BRCA-Mutated Ovarian Cancer
ZEJULA is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAmut) recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.
From the FDA-approved label on DailyMed (published Aug 06, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02530031.
- It names Zejula, Niraparib Tosylate 100 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Zejula by Glaxosmithkline Inc.
In Canada: prescription only.
Ingredients
Active: Niraparib (Niraparib Tosylate)
Other Niraparib pills
- 100 Zejula Niraparib 100 mg Gray, oval, 12 mm Used for fallopian tube neoplasms and ovarian neoplasms
- 200 Zejula Niraparib 200 mg Blue, oval, 16 mm Used for fallopian tube neoplasms and ovarian neoplasms
- 300 Zejula Niraparib 300 mg Green, oval, 19 mm Used for fallopian tube neoplasms and ovarian neoplasms